ストックスクリーナーアプリを入手
5.59
35.35%
1.46
アフターアワーズ：
5.57
-0.02
-0.36%
Evolus Inc (EOLS) 最新ニュース
Evolus Q4 2025 slides: revenue growth continues despite forecast miss By Investing.com - Investing.com Australia
EOLS SEC FilingsEvolus 10-K, 10-Q, 8-K Forms - Stock Titan
Evolus posts record rally after Q4 beat (EOLS:NASDAQ) - Seeking Alpha
Evolus (NASDAQ:EOLS) Issues Quarterly Earnings Results - MarketBeat
Evolus' (EOLS) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Evolus, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
BTIG Reiterates Buy Rating for Evolus (EOLS) with $13 Target | E - GuruFocus
US Stock Movement | Evolus rises over 16% pre-market as Q4 revenue growth achieves breakeven, positive guidance for this quarter - Bitget
Evolus (EOLS) Projects Growth with Strategic Initiatives and New Product Launches - GuruFocus
Evolus earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Evolus Inc (EOLS) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Aug Sectors: What analysts say about Evolus Inc stockTrade Risk Assessment & AI Enhanced Trading Alerts - baoquankhu1.vn
Earnings call transcript: Evolus misses Q4 2025 revenue forecast, stock dips - Investing.com South Africa
Evolus Q4 Earnings Call Highlights - MarketBeat
Evolus Shares Up 17% on Q4, Full Year Earnings - Orange County Business Journal
Evolus, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:EOLS) 2026-03-03 - Seeking Alpha
Evolus (EOLS) Q4 2025 Earnings Call Transcript - AOL.com
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates - Yahoo Finance
Evolus (NASDAQ: EOLS) outlines 2025 losses, Jeuveau and Evolysse growth plans - Stock Titan
EOLS Projects Strong Financial Growth Through 2028 - GuruFocus
Evolus : Investor Presentation - marketscreener.com
Evolus Incenters loan and security agreement with Eclipse Business Capital on March 3, 2026SEC filing - marketscreener.com
EOLS Reports Strong Q4 Revenue Surpassing Expectations - GuruFocus
Evolus Posts Q4 Breakeven Results, Revenue Rises; Shares Gain After Hours - marketscreener.com
Evolus 2025 10-K: $297.2M Revenue, $(0.80) EPS - TradingView
Evolus Secures New Credit Facility and Reports Profitability - TipRanks
Evolus Q4 Earnings Summary & Key Takeaways - Benzinga
Evolus Inc. (EOLS) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Evolus (NASDAQ: EOLS) wins $30M credit line and 12% 2025 sales rise - Stock Titan
Evolus, Inc. Provides Earnings Guidance for 2026 - marketscreener.com
EOLS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Evolus recently officially disclosed its financial results for the fourth quarter and full year of 2025. - Bitget
Evolus Shares Earn 'Moderate Buy' Rating from Analysts - National Today
What to Expect from Evolus's Earnings - Benzinga
Evolus, Inc. (NASDAQ:EOLS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Evolus, Inc. (EOLS) Stock Analysis: A 237% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Evolus to join Leerink Partners Healthcare Conference for fireside chat and strategy talks - Traders Union
Evolus to Participate in The Leerink Partners Global Healthcare Conference - ChartMill
Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz
Evolus (EOLS) Expected to Announce Earnings on Tuesday - MarketBeat
Aug Highlights: How volatile is CTEV stockTrend Reversal & High Accuracy Investment Entry Signals - baoquankhu1.vn
Evolus, Inc. (EOLS) Stock Analysis: A Potential 243% Upside Ignites Investor Interest - DirectorsTalk Interviews
Evolus (EOLS) awards RSUs and stock options to officer Rui Avelar - Stock Titan
Evolus (NASDAQ: EOLS) grants RSUs, PSUs and options to executive David Moatazedi - Stock Titan
How sustainable is Evolus Inc. stock dividend payoutWeekly Stock Recap & Intraday High Probability Setup Alerts - mfd.ru
Director at Evolus (EOLS) receives 45,559 restricted stock units in equity grant - Stock Titan
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead - Intellectia AI
Caligan exits Evolus (EOLS), amended filing shows 0% ownership - Stock Titan
Major holder Timothy P. Lynch reports 9.9% stake in Evolus (EOLS) - Stock Titan
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 - BioSpace
BTIG Initiates Coverage of Evolus (EOLS) with Buy Recommendation - MSN
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 13, 2026 - BioSpace
How Evolus Inc. stock compares to growth peers2025 Volume Leaders & High Yield Equity Trading Tips - mfd.ru
Is Evolus Inc. undervalued by DCF analysis2025 Trade Ideas & High Conviction Buy Zone Picks - mfd.ru
What Catalysts Are Rewriting The Evolus (EOLS) Story After The Guidance Reset - Yahoo Finance
Mizuho Lowers Price Target on Evolus, Inc. (EOLS) to $15, Maintains Outperform Rating - Insider Monkey
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
CEO Change: Is Evolus Inc undervalued by DCF analysis2025 Trade Ideas & AI Driven Price Forecasts - baoquankhu1.vn
Aug Patterns: Is Evolus Inc showing insider buyingMarket Trend Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Evolus, Inc. (NASDAQ:EOLS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
What is HC Wainwright's Forecast for Evolus FY2026 Earnings? - MarketBeat
0.21%
1.77%
大文字化:
|
ボリューム (24 時間):